Levetiracetam Generis

Levetiracetam, the active ingredient in Levetiracetam Generis, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to control various seizure types within the epileptic disorder spectrum.

Partial seizures: reduces the frequency of focal onset seizures in patients with epilepsy. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy. Myoclonic seizures: decreases myoclonic jerks in appropriate patient populations.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate cranial pain. - Irritability: mood changes or agitation. - Nausea: mild gastrointestinal discomfort. - Fatigue: general lack of energy.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Psychiatric events: depression, suicidal thoughts, or aggressive behavior. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions. - Blood dyscrasias: neutropenia or thrombocytopenia. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Before initiating therapy, clinicians should consider several safety aspects.

Renal impairment: adjust dose based on creatinine clearance. Psychiatric monitoring: observe for mood changes, depression, or suicidal ideation. Abrupt discontinuation: taper gradually to avoid seizure exacerbation. Elderly patients: start at lower dose and monitor tolerability. Hypersensitivity: avoid in patients with known allergy to levetiracetam. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing levetiracetam plasma levels. - Phenytoin: enzyme induction may lower levetiracetam concentrations. - Rifampin: strong inducer that can decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase levetiracetam levels modestly. - Oral contraceptives: levetiracetam may reduce hormonal efficacy; consider alternative contraception. - Alcohol: additive CNS depression may enhance somnolence.